The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Teehan Brendan since 2022.
This trader's CIK number is 1891900.
At the time of last reporting, Teehan Brendan was the EVP, COO, HEAD OF COMMERCIAL of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD).
Also see all insider trading activities at Acadia Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ACAD | 0 | $0 | 32,403 | $553,398 | 34,058 | $0 |
| 2023 | ACAD | 0 | $0 | 23,121 | $508,020 | 48,634 | $0 |
| 2022 | ACAD | 0 | $0 | 1,090 | $22,436 | 2,853 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-17 | ACAD | Option Ex | 19,826 | .00 | 0 |
| 2024-11-19 | ACAD | Sale | 10,329 | 16.81 | 173,630 |
| 2024-08-19 | ACAD | Sale | 9,534 | 15.28 | 145,679 |
| 2024-05-02 | ACAD | Sale | 3,477 | 16.94 | 58,900 |
| 2024-05-01 | ACAD | Option Ex | 6,814 | .00 | 0 |
| 2024-04-08 | ACAD | Sale | 2,568 | 17.87 | 45,890 |
| 2024-04-05 | ACAD | Option Ex | 5,024 | .00 | 0 |
| 2024-03-27 | ACAD | Sale | 5,140 | 17.90 | 92,005 |
| 2024-02-26 | ACAD | Sale | 624 | 24.67 | 15,394 |
| 2024-02-23 | ACAD | Option Ex | 1,107 | .00 | 0 |
| 2024-01-06 | ACAD | Option Ex | 1,287 | .00 | 0 |
| 2024-01-08 | ACAD | Sale | 731 | 29.96 | 21,900 |
| 2023-11-20 | ACAD | Sale | 4,960 | 22.64 | 112,294 |
| 2023-11-17 | ACAD | Option Ex | 9,912 | .00 | 0 |
| 2023-05-17 | ACAD | Option Ex | 29,738 | .00 | 0 |
| 2023-05-17 | ACAD | Sale | 14,869 | 22.50 | 334,552 |
| 2023-04-29 | ACAD | Option Ex | 1,567 | .00 | 0 |
| 2023-05-01 | ACAD | Sale | 548 | 21.18 | 11,606 |
| 2023-04-05 | ACAD | Option Ex | 5,024 | .00 | 0 |
| 2023-04-06 | ACAD | Sale | 1,751 | 18.16 | 31,798 |
| 2023-02-24 | ACAD | Sale | 461 | 18.78 | 8,657 |
| 2023-02-23 | ACAD | Option Ex | 1,107 | .00 | 0 |
| 2023-01-06 | ACAD | Option Ex | 1,286 | .00 | 0 |
| 2023-01-09 | ACAD | Sale | 532 | 17.13 | 9,113 |
| 2022-04-29 | ACAD | Option Ex | 1,567 | .00 | 0 |
| 2022-05-02 | ACAD | Sale | 552 | 18.18 | 10,036 |
| 2022-01-06 | ACAD | Option Ex | 1,286 | .00 | 0 |
| 2022-01-06 | ACAD | Sale | 538 | 23.05 | 12,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Teehan Brendan (EVP, COO, HEAD OF COMMERCIAL of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.